Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of clopidogrel response on the clinical evolution in patients with acute coronary syndromes.

Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi - 1 Jan 2000

Costache Irina Iuliana, Rusu Cristina, Ivanov I, Popescu Roxana, Petriş A

Abstract excerpt

AIM: the purpose of the present study was to determine the relationship between the Clopidogrel genetic response (based on laboratory specific tests) and the worse evolution of the patients with acute coronary syndromes. MATERIAL AND METHODS: The study included 80 patients (11 females and 69 male...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Coronary Syndrome
Share to Aryl Hydrocarbon Hydroxylases
Share to Aspirin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Clopidogrel

Share to Cytochrome P-450 CYP2C19

Share to Platelet Aggregation Inhibitors

Share to Ticlopidine

Share to Treatment Failure

Source

Identifiers

PMID: 23700873

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23700873-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of clopidogrel response on the clinical evolution in patients with acute coronary syndromes.PMID 23700873Read ↗

[Effects of clopidogrel resistence and CYP2C19 genotype on the clinical prognosis of patients with acute coronary syndrome undergoing percutaneous coronary intervention].Semantic proximity Read ↗

Dynamic changes and associated factors of clopidogrel resistance in patients after cerebral infarction.Semantic proximity Read ↗

[Clopidogrel resistance--risk factor in patients with acute coronary syndromes].Semantic proximity Read ↗

Optimisation of anti-platelet therapy in acute coronary syndromesSemantic proximity Read ↗

Influence of Genetic Polymorphisms in P2Y12 Receptor Signaling Pathway on Antiplatelet Response to Clopidogrel in Coronary Heart DiseaseSemantic proximity Read ↗

Review of aspirin and clopidogrel resistance in peripheral arterial disease.Semantic proximity Read ↗

[Relationship between ATP-binding cassette subfamily B member 1 and cytochrome P450 2C19 polymorphisms and the effect of clopidogrel post percutaneous coronary intervention in patients with acute coronary syndrome].Semantic proximity Read ↗

Whole blood dynamic platelet aggregation counting and 1-year clinical outcomes in patients with coronary heart diseases treated with clopidogrel.Semantic proximity Read ↗

Clopidogrel in acute coronary syndrome: to genotype or not?Semantic proximity Read ↗

Factors that contribute to clopidogrel resistance in cardiovascular disease patients: environmental and genetic approach.Semantic proximity Read ↗

Options to overcome clopidogrel response variability.Semantic proximity Read ↗

[Clinical impact and underlying mechanism of clopidogrel response variability].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.